Brachial Plexus Injury Market Overview 2024-2033 – Competitive Landscape and Strategies

The Brachial Plexus Injury Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Brachial Plexus Injury Market:
https://www.thebusinessresearchcompany.com/report/brachial-plexus-injury-global-market-report

According to The Business Research Company’s Brachial Plexus Injury Global Market Report 2024, The brachial plexus injury market size has grown rapidly in recent years. It will grow from $5.1 billion in 2023 to $5.73 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to the increasing incidence of trauma due to road accidents and sports injuries, growing awareness and early diagnosis of brachial plexus injuries, improvements in healthcare infrastructure and accessibility to treatment, a rising geriatric population prone to neurological conditions, the expansion of healthcare insurance coverage for complex surgeries, and regulatory approvals for novel treatment options.

The brachial plexus injury market size is expected to see rapid growth in the next few years. It will grow to $9.22 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to an aging population leading to higher demand for nerve repair solutions, integration of advanced imaging techniques for accurate diagnosis, adoption of minimally invasive surgical procedures, investments in R&D for biologics and tissue engineering, increasing healthcare expenditure in developing economies, and collaboration between medical device companies and research institutions. Major trends in the forecast period include adoption of robotic-assisted surgery for precise nerve reconstruction, growth in telemedicine and virtual consultations for post-operative care, development of bioresorbable materials for nerve conduits, use of artificial intelligence for patient-specific treatment plans, expansion of outpatient surgical centers for quicker recovery times, emphasis on patient-reported outcomes and quality of life improvements, and a and a shift towards personalized medicine and tailored rehabilitation programs.

An increase in the number of road accidents is expected to propel the growth of the brachial plexus injury market going forward. The increased vehicle usage and inadequate enforcement of traffic laws exacerbate risks associated with speeding and driver negligence, leading to a rise in road accident cases. Brachial plexus injury treatment in road accidents typically involves a combination of surgical interventions, such as nerve grafting or nerve transfer procedures, alongside rehabilitative therapies to restore function and mobility to the affected limb. For instance, in January 2024, according to a report published by The Road Safety Authority, an Ireland-based state government agency, as per preliminary traffic collision data, the number of road deaths in 2023 increased by 19% compared to 2022. Therefore, an increase in the number of road accidents is driving the brachial plexus injury market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18268&type=smp

The brachial plexus injury market covered in this report is segmented –

1) By Type: Avulsion, Rupture, Neurapraxia, Axonotmesis, Neurotmesis, Neuroma
2) By Diagnosis: Clinical Examination, Electrodiagnostic, Imaging Studies
3) By Treatment: Therapy, Surgery
4) By Indication: Trauma, Inflammation, Contact Sports, Tumors, Radiation Treatment, Other Indications

Major companies operating in the brachial plexus injury market are developing advanced medical therapies, such as long-acting local analgesics, to enhance pain management. Long-acting local analgesics are pivotal in managing pain in brachial plexus injuries, offering sustained relief via nerve blocks or local infiltration techniques, thus improving patient comfort, supporting rehabilitation, and minimizing systemic side effects associated with traditional pain medications. For instance, in March 2021, Pacira BioSciences Inc., a US-based specialty pharmaceutical company, received FDA approval to expand the label for its non-opioid pain medication EXPAREL (bupivacaine liposome injectable suspension. It contains two additional nerve block indications, such as Adductor canal block, which is used in adult patients to provide regional analgesia for lower extremity treatments, and Sciatic nerve block in the popliteal fossa of adult patients to provide regional analgesia during lower extremity surgeries. The supplemental new drug application (sNDA) is based on two successful Phase 3 studies in which EXPAREL achieved statistically significant and clinically meaningful reductions in postsurgical pain and opioid consumption over 96 hours when compared to bupivacaine HCl after lower extremity surgical procedures such as bunionectomy and total knee arthroplasty.

The brachial plexus injury market report table of contents includes:

1. Executive Summary
2. Brachial Plexus Injury Market Characteristics
3. Brachial Plexus Injury Market Trends And Strategies
4. Brachial Plexus Injury Market – Macro Economic Scenario
5. Global Brachial Plexus Injury Market Size and Growth
.
.
.
32. Global Brachial Plexus Injury Market Competitive Benchmarking
33. Global Brachial Plexus Injury Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Brachial Plexus Injury Market
35. Brachial Plexus Injury Market Future Outlook and Potential Analysis
36. Appendix